SOHM Inc (SHMN)

[john12341]

Company Overview
SOHM, Inc. (SHMN) is a pharmaceutical manufacturer that produces and markets generic drugs for all major treatment
categories. In February, 2009, the Company obtained a direct manufacturing license under Current Good Manufacturing
Practice (CGMP) and initiated processes to be compliant with World Health Organization (WHO) regulations to produce

generic as well as OTC pharmaceuticals. This authorization process provides the Company with manufacturing
competencies for a wide variety of products covering various therapeutic segments. SHMN has private label license
agreements with two companies to produce pharmaceuticals and OTC products.

The Company’s strategic manufacturing facility enables low production costs without compromising quality. SHMN
develops, manufactures and markets generic pharmaceuticals in various dosage forms, including tablets and capsules,
creams and topicals, ointments, liquids and injectables. At present, SHMN has global licenses to manufacture more than
15 products and approximately 300 generic drugs and product formulations for distribution.

SHMN markets and sells its generic drugs globally but focuses primarily on emerging markets in Africa, Latin America,
Southeast Asia and the European Union. The Company’s global headquarters is located in North America and it has
offices in China, India and the U.K.

source page seven in link
https://backend.otcmarkets.com/otcapi/company/financial-report/278001/content

now that would account for our private labelers and sales from sohm india pvt limited and Novatrend Medicament Pvt. Ltd


that goes with this post
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=164223943